netFormulary Kettering General Hospital NHS
NHS Foundation Trust  
 Search
 Formulary Chapter 11: Eye - Full Chapter
11.08.02  Expand sub section  Ocular diagnostic and peri-operative preparations and photodynamic treatment
11.08.02  Expand sub section  Ocular diagnostic preparations
11.08.02  Expand sub section  Ocular peri-operative drugs
11.08.02  Expand sub section  Subfoveal choroidal neovascularisation
Brolucizumab (Boevu)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red

Intravitreal 19.8 mg brolucizumab in 0.165 ml solution

 

 
Link  Brolucizumab for treating wet age-related macular degeneration
Link  
   
Ranibizumab (Lucentis)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
High Cost Medicine
CCG
BlueTeq

Intravitreal injection 2.3mg/0.23ml (10mg/ml)

 
Link  NICE TA274: Macular oedema (diabetic)
Link  NICE TA283: Macular oedema (retinal vein occlusion)
Link  NICE TA298: Choroidal neovascularisation (pathological myopia)
   
11.08.02  Expand sub section  Vitreomacular traction to top
 ....
 Non Formulary Items
Bevacizumab  (Avastin)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Pegaptanib Sodium  (Macugen®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Verteporfin  (Visudyne)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Amber 1

"Amber 1" - These are medicines that require significant monitoring and the decision to treat with an AMBER medicine should be made by specialists only  

Amber 2

"Amber 2" - These are medicines that require little or no monitoring by the GP, but should only be prescribed in general practice after they have been recommended following specialist referral.  

Red

"Red" - Secondary care only  

RedRed

"Double Red" - NOT recommended for prescribing in either primary or secondary care  

Grey

Traffic light status to be confirmed  

Green

May be prescribed in primary and secondary care  

netFormulary